Blumberg Capital β 2024 Investments
5 investments dated 2024 Β· listed companies and verified rows first Β· show all
Miami, US
Michael True(Executive Officer, Director)Cody Greco(Director)
Board seatBruce TaraginΒ· per SEC Form D Β· $10.3M raise Β· filed Feb 2024
Ferrum Health develops AI accountability solutions, though the specific products and customer base are not detailed on the company page.
AI & Machine LearningDigital HealthEnterprise SoftwareSunnyvale, US
Pelu Tran(Executive Officer, Director)in
BoardPatrick Steele(Director)inJaclyn Hester(Director)inKenneth Ko(Director)
Co-investorsFoundryHeadwater VenturesInformed Ventures Advisors, LlcUrban InnovationGSR
Overview AI builds AI-powered vision systems that detect manufacturing defects in real-time across production lines, learning and adapting to any product within hours.
Advanced ManufacturingAI & Machine LearningDeep TechIoTRoboticsSan Francisco, US
Austin Appel(Founder)inRussell Nibbelink(Founder)inChristopher Van Dyke(Founder)inXiaoyang Kao(Co-Founder & Head of Engineering)inChris Van Dyke(Founder)inXiao Kao(Cofounder)
Co-investorsHomebrewMomenta VenturesTRAC (Third Round Analytics Capital)Y Combinator
Prescient AI offers a marketing mix modeling platform that measures the true impact of marketing channels, accounting for halo effects, saturation, and cross-channel dynamics that platform reporting misses, with models that update daily.
AdTechAI & Machine LearningMarketing TechSaaS
Michael True(Co-founder)inCody Greco(Co-founder & CTO)inWill Holtz(Interim CEO)inJose Orue(Head of Product)in
Co-investorsGreen Egg VenturesOutbound VenturesDarling VenturesFocal VenturesHeadline
Prescient AI provides a media mix modeling platform that measures the direct and halo effects of each marketing channel and offers budget optimization, predictive forecasting, and saturation-curve analysis.
AdTechAI & Machine LearningMarketing Tech
Co-investorsFocal VenturesMaccabee VenturesDarling VenturesHeadline
Rows marked βSEC filingβ are inferred from directors named on the company's SEC Form D β public regulatory data, not a portfolio list published by the firm.
